Ticagrelor Use in Acute Myocardial Infarction: Insights From the National Cardiovascular Data Registry

BACKGROUND: Ticagrelor is a P2Y(12) receptor inhibitor with superior clinical efficacy compared with clopidogrel. However, it is associated with reduced efficacy when combined with a high‐dose aspirin. METHODS AND RESULTS: Patients in the acute coronary treatment and intervention outcomes network (A...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Am Heart Assoc
Main Authors: Basra, Sukhdeep S., Wang, Tracy Y., Simon, DaJuanicia N., Chiswell, Karen, Virani, Salim S., Alam, Mahboob, Nambi, Vijay, Denktas, Ali E., Deswal, Anita, Bozkurt, Biykem, Ballantyne, Christie M., Peterson, Eric D., Jneid, Hani
Formato: Artigo
Idioma:Inglês
Publicado: John Wiley and Sons Inc. 2018
Assuntos:
Original Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6220549/
https://ncbi.nlm.nih.gov/pubmed/29886424
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.117.008125
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares